Hospital Gregorio Maranon
Madrid 37007
2 studies enrolling now · 16 studies all time
What they study most
Acute Ischemic Stroke, Acute Respiratory Distress Syndrome, Angioplasty, Transluminal, Percutaneous Coronary, Atrial Fibrillation, Atrial Flutter, Breast Cancer, Cardiomyopathy, Cushing's Syndrome, Extracorporeal Membrane Oxygenation, Fallopian Tube Cancer, Hepatocellular Carcinoma, Hidradenitis Suppurativa (HS)
Studies at this site
- Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis — Recruiting now
- A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa — Recruiting now
- TheraSphere With Durvalumab and Tremelimumab for HCC — Running, not enrolling
- ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND) — Running, not enrolling
- A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma — Running, not enrolling
- Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 — Completed
- Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer — Completed
- Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) — Completed
- An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML) — Completed
- Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window — Completed
- Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing — Completed
- Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer — Completed
- Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke — Stopped early
- Trial of Dacarbazine With or Without Genasense in Advanced Melanoma — Completed
- The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed
- A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed